NEW YORK (GenomeWeb) – Genetics services firm InformedDNA today said that it has reached a $4.5 million funding agreement with Blue Cross Blue Shield of Massachusetts' wholly owned subsidiary Zaffre Investments.

InformedDNA will use the funds to expand its use of information technology in order to improve the efficiency and capacity of its genetics benefits utilization management capabilities. The company added that the investment also will go toward the management of its rapid growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.